BioCentury
ARTICLE | Distillery Therapeutics

Cancer

April 4, 2017 10:08 PM UTC

Mouse studies suggest combining MSN inhibition with adoptive T cell therapy could help treat melanoma. In a mouse model of melanoma receiving mouse CD8+ T cells expressing a melanoma antigen, systemic...

BCIQ Target Profiles

Moesin (MSN)